WallStreetZenWallStreetZen

NASDAQ: IPSC
Century Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IPSC past revenue growth

How has IPSC's revenue growth performed historically?
Company
-57.01%
Industry
144.63%
Market
17.55%
IPSC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IPSC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IPSC earnings and revenue history

Current Revenue
$2.2M
Current Earnings
-$136.7M
Current Profit Margin
-6,115.1%

IPSC Return on Equity

Current Company
-58.9%
Current Industry
-63.5%
Current Market
188%
IPSC's Return on Equity (-58.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IPSC announces earnings.

IPSC Return on Assets

Current Company
-33.5%
Current Industry
2.9%
IPSC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IPSC Return on Capital Employed

Current Company
-39.16%
Current Industry
19.5%
IPSC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IPSC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IPSC$2.24M-$122.40M-$136.67M-57.01%N/A
CDXS$70.14M-$66.25M-$76.24M+2.97%N/A
VERU$15.93M-$62.11M-$64.59M-4.11%N/A
CADL$0.00-$34.14M-$37.94MN/AN/A
ABOS$0.00-$51.61M-$52.37MN/AN/A
View Top Biotech Stocks

IPSC earnings dates

Next earnings date
May 13, 2024

Century Therapeutics Earnings & Revenue FAQ

What were IPSC's earnings last quarter?

On Invalid Date, Century Therapeutics (NASDAQ: IPSC) reported Q4 2023 earnings per share (EPS) of -$0.65, up 18.18% year over year. Total Century Therapeutics earnings for the quarter were -$39.40 million. In the same quarter last year, Century Therapeutics's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Century Therapeutics stock.

What was IPSC's earnings growth in the past year?

As of Q2 2024, Century Therapeutics's earnings has grown year over year. Century Therapeutics's earnings in the past year totalled -$136.67 million.

What is IPSC's earnings date?

Century Therapeutics's earnings date is Invalid Date. Add IPSC to your watchlist to be reminded of IPSC's next earnings announcement.

What was IPSC's revenue last quarter?

On Invalid Date, Century Therapeutics (NASDAQ: IPSC) reported Q4 2023 revenue of $268.00 thousand up 48.56% year over year. In the same quarter last year, Century Therapeutics's revenue was $521.00 thousand.

What was IPSC's revenue growth in the past year?

As of Q2 2024, Century Therapeutics's revenue has grown -57.01% year over year. This is 201.64 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Century Therapeutics's revenue in the past year totalled $2.24 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.